Aelis Farma: Combined General Meeting of May 24, 2023: Avail

Aelis Farma (ISIN: FR0014007ZB4 Ticker: AELIS, PEA-PME eligible) (Paris: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, informs

Related Keywords

United States , Spain , Paris , France General , France , Vincenzo Piazza , Magendie Neurocenter , Daelis Farma , Arthur Rouill , Twitter , Linkedin , Combined General Meeting , Lafaurie De Mondabon , General Meeting , Investors General , Commercial Code , Signaling Specific , Pier Vincenzo Piazza , Down Syndrome , Euronext Paris , Universal Registration Document , Des March , Saelis , Sarma , Combined , Eneral , Meeting , 023 , Availability , Preparatory , Documents , Participation , Voting , Procedures ,